Progenics To Reformulate Drug
Progenics Pharmaceuticals Inc. (PGNX) will reformulate its constipation treatment methylnaltrexone to improve effectiveness. The stock price plunged $4.19 to close at $22.57.
posted by FC Market News at 3:00 PM
0 Comments:
Post a Comment
<< Home